Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells

Advanced NSCLC patients harboring EML4-ALK and CCDC6-RET rearrangements derive benefit from treatment with ALK and RET TKIs but not immune checkpoint inhibitors. New immunotherapeutic approaches, such as immunization against growth factors, can be of particular interest for combination treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Codony-Servat, Jordi, García-Roman, Silvia, Molina-Vila, Miguel Ángel, Bertran-Alamillo, Jordi, Viteri, Santiago, d'Hondt, Erik, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591385/
https://www.ncbi.nlm.nih.gov/pubmed/33129112
http://dx.doi.org/10.1016/j.tranon.2020.100887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591385/
https://www.ncbi.nlm.nih.gov/pubmed/33129112
http://dx.doi.org/10.1016/j.tranon.2020.100887

Ejemplares similares